Daiichi Sankyo Company, Limited (TYO:4568)
2,909.50
+17.00 (0.59%)
Nov 4, 2026, 3:30 PM JST
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 20,171 employees as of March 31, 2026. The number of employees increased by 406 or 2.05% compared to the previous year. That makes Daiichi Sankyo Company the 1,814th largest employer in the world and 174th in Japan.
Employees
20,171
Change (1Y)
406
Growth (1Y)
2.05%
Revenue / Employee
114.77M JPY
Profits / Employee
14.90M JPY
Market Cap
5.30T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 20,171 | 406 | 2.05% |
| Mar 31, 2025 | 19,765 | 1,039 | 5.55% |
| Mar 31, 2024 | 18,726 | 1,291 | 7.40% |
| Mar 31, 2023 | 17,435 | 977 | 5.94% |
| Mar 31, 2022 | 16,458 | 425 | 2.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Otsuka Holdings | 37,758 |
| HOYA Corporation | 37,752 |
| Olympus | 28,138 |
| M3, Inc. | 17,010 |
| Astellas Pharma | 14,099 |
| Eisai | 10,543 |
| Shionogi & | 6,223 |
Daiichi Sankyo Company News
- 4 days ago - Daiichi Sankyo Company Earnings Call Transcript: Q2 2027 - Transcripts
- 4 days ago - Daiichi Sankyo Company Quarterly report: Q2 2027 - Filings
- 4 days ago - Daiichi Sankyo Company Slides: Q2 2027 - Filings
- 5 days ago - Daiichi Sankyo Reports Second Quarter Fiscal Year 2026 Financial Results - Business Wire
- 5 days ago - Two Single-Pill Triple Combination Lipid-Lowering Therapy Applications Validated in The European Union - Business Wire
- 12 days ago - Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO - Business Wire
- 4 weeks ago - AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
- 5 weeks ago - Merck, Daiichi Sankyo withdraw US application for lung cancer drug - Reuters